Tag: Aspirin
Bleeding Risks for Oral Anticoagulants and Aspirin Mostly Similar
Similar risks seen for apixaban and dabigatran versus aspirin, while rates were higher for rivaroxaban
Daily, Long-Term Aspirin Use Reduces Colorectal Cancer Recurrence
Findings seen for patients with somatic alterations in the PI3K signaling pathway
Primary Prevention Aspirin Use Decreased After Recommendation Change
Decrease in use seen among older adults, adults with low ASCVD risk, but also among those with higher ASCVD risk
Aspirin-Linked Reduction in CRC Risk Varies With Lifestyle Score
Greater absolute risk reduction seen in those with less healthy lifestyles
Medically Advised Aspirin Use Lower in 2021 Than 2012 to 2017
29.7 percent of those aged 60 years or older reported primary prevention use in 2021, with 5.2 percent using without medical advice
Aspirin Provides No Benefit for Breast Cancer Recurrence, Survival
Findings seen among people with high-risk nonmetastatic breast cancer at a median 33.8 months
Aspirin May Enhance Immunosurveillance Against Colorectal Cancer
Aspirin users have nodal metastases significantly less often, higher infiltration of tumor-infiltrating lymphocytes
New Stroke Risk Down With Clopidogrel-Aspirin Initiated Within 72 Hours
Findings seen among patients with mild ischemic stroke or high-risk transient ischemic attack of presumed atherosclerotic cause
AHA: Avoidance of Aspirin Noninferior With LVAD in Advanced Heart Failure
Findings seen among patients with advanced heart failure receiving support from a fully magnetically levitated left ventricular assist device
TCT: Ticagrelor Monotherapy Within One Month of DAPT Noninferior to Continued DAPT
Major bleeding occurred in fewer patients in group receiving ticagrelor monotherapy after less than one month of DAPT versus 12-month DAPT group
